The Patent Finder

Icon Genetics GmbH

11 patents currently held · Updated Nov 16, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
Sep 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 8, 2027
    The maintenance fee for Method of co-expressing a glycoprotein and a single-subunit olicosaccharyltransferase in a plant (US 10,435,704) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
  • 1 fee due May 10, 2027
    The maintenance fee for Production of galactosylated N-glycans in plants (US 9,181,532) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
  • 1 fee due Aug 23, 2027
    The maintenance fee for Rna virus-derived plant expression system (US 9,267,143) comes due Aug 23, 2027. Unpaid by Feb 23, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,415,463Potexvirus-derived replicon
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,093,458Biologically safe transient protein expression in plants
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,267,143Rna virus-derived plant expression system
In force
 · Medium confidence
In forceMedium confidence
US 8,624,080Plant virus-based inducible expression system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,940,963Production of hetero-oligomeric proteins in plants
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,883,420Process of clean cloning
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,597,937System and Method of Modular Cloning
In force
 · Medium confidence
In forceMedium confidence
US 9,181,532Production of galactosylated N-glycans in plants
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,435,704Method of co-expressing a glycoprotein and a single-subunit olicosaccharyltransferase in a plant
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,196,664Nicotiana Benthamiana Plants Deficient in Fucosyltransferase Activity
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 1 patent in force now held by others · 23 lapsed for an unpaid fee · 10 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 10 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited